Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo
We report the use of plasmid DNA-mediated combination gene therapy for tumor-bearing mice using in vivo electroporation, also called electro-gene therapy (EGT), that resulted in uncomplicated and complete cures in more than 90% of the mice. Subcutaneously inoculated CT26 tumors in syngeneic BALB/c m...
Gespeichert in:
Veröffentlicht in: | Molecular therapy 2004-11, Vol.10 (5), p.929-937 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 937 |
---|---|
container_issue | 5 |
container_start_page | 929 |
container_title | Molecular therapy |
container_volume | 10 |
creator | Goto, Tomoaki Nishi, Toru Kobayashi, Osamu Tamura, Takahiko Dev, Sukhendu B Takeshima, Hideo Kochi, Masato Kuratsu, Jun-ichi Sakata, Tsuneaki Ushio, Yukitaka |
description | We report the use of plasmid DNA-mediated combination gene therapy for tumor-bearing mice using in vivo electroporation, also called electro-gene therapy (EGT), that resulted in uncomplicated and complete cures in more than 90% of the mice. Subcutaneously inoculated CT26 tumors in syngeneic BALB/c mice were subjected to repeated EGT treatments consisting of intratumoral co-injection of naked plasmids encoding the cytokine interleukin-12 (IL-12) (p35 and p40 subunits) and the suicide gene herpes simplex virus thymidine kinase (HSV-tk), followed by in vivo electroporation. The early anti-tumor effect was always stronger, and the rate of cure, as seen in the long-term follow-up, was always greater in the groups treated with combination EGT than in those treated with IL-12 or HSV-tk EGT alone. Systemic levels of IL-12 and IFN-gamma increased in both combination and IL-12-alone EGT-treated groups. Moreover, combination EGT for established subcutaneous tumors strongly reduced hematogenous lung metastases and increased survival time when live CT26 tumor cells were injected through the tail vein. Limited experiments on C57/B16 mice with murine melanoma also showed very similar trends. These results suggest that this simple and safe method of plasmid-mediated combination EGT may provide a potentially effective gene therapy for cancer. |
doi_str_mv | 10.1016/j.ymthe.2004.07.028 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67019176</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67019176</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-3e89b41ac9f1c6c4a268903799f91ec10aa2902229c4d55398061f6c4209b66f3</originalsourceid><addsrcrecordid>eNpdkV2L1DAUhoMo7ucvECQgeNduTtqmzaUMfsGCN-t1yGROZzK2Sc1pl-3P8Z-acQcFr3KSPO-bwMPYGxAlCFB3x3Id5wOWUoi6FG0pZPeCXUIjm0IIWb_8O4O6YFdExzxBo9VrdgFNI3QD4pL92sRx64OdfQwcB3RzisUeA_Jcney08oV82PO8mZD4o08L5at19DufoR85Ssht2HEfZkwDLvmoAMnxaUpIdKqdBkuZJ-6JH_z-MKwc-947j2Hmdm99oJmPSzoVOpucD3G0mQ75ucd4w171diC8Pa_X7Punjw-bL8X9t89fNx_uC1e19VxU2OltDdbpHpxytZWq06Jqte41oANhrdRCSqldvWuaSndCQZ9BKfRWqb66Zu-fe6cUfy5Isxk9ORwGGzAuZFQrQEOrMvjuP_AYlxTy3wy0WnYAVaczVT1TLkWihL2Zkh9tWg0Ic_JnjuaPP3PyZ0Rrsr-cenvuXrYj7v5lzsKq30p1mwk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1792811389</pqid></control><display><type>article</type><title>Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Goto, Tomoaki ; Nishi, Toru ; Kobayashi, Osamu ; Tamura, Takahiko ; Dev, Sukhendu B ; Takeshima, Hideo ; Kochi, Masato ; Kuratsu, Jun-ichi ; Sakata, Tsuneaki ; Ushio, Yukitaka</creator><creatorcontrib>Goto, Tomoaki ; Nishi, Toru ; Kobayashi, Osamu ; Tamura, Takahiko ; Dev, Sukhendu B ; Takeshima, Hideo ; Kochi, Masato ; Kuratsu, Jun-ichi ; Sakata, Tsuneaki ; Ushio, Yukitaka</creatorcontrib><description>We report the use of plasmid DNA-mediated combination gene therapy for tumor-bearing mice using in vivo electroporation, also called electro-gene therapy (EGT), that resulted in uncomplicated and complete cures in more than 90% of the mice. Subcutaneously inoculated CT26 tumors in syngeneic BALB/c mice were subjected to repeated EGT treatments consisting of intratumoral co-injection of naked plasmids encoding the cytokine interleukin-12 (IL-12) (p35 and p40 subunits) and the suicide gene herpes simplex virus thymidine kinase (HSV-tk), followed by in vivo electroporation. The early anti-tumor effect was always stronger, and the rate of cure, as seen in the long-term follow-up, was always greater in the groups treated with combination EGT than in those treated with IL-12 or HSV-tk EGT alone. Systemic levels of IL-12 and IFN-gamma increased in both combination and IL-12-alone EGT-treated groups. Moreover, combination EGT for established subcutaneous tumors strongly reduced hematogenous lung metastases and increased survival time when live CT26 tumor cells were injected through the tail vein. Limited experiments on C57/B16 mice with murine melanoma also showed very similar trends. These results suggest that this simple and safe method of plasmid-mediated combination EGT may provide a potentially effective gene therapy for cancer.</description><identifier>ISSN: 1525-0016</identifier><identifier>EISSN: 1525-0024</identifier><identifier>DOI: 10.1016/j.ymthe.2004.07.028</identifier><identifier>PMID: 15509510</identifier><language>eng</language><publisher>United States: Elsevier Limited</publisher><subject>Animals ; Cancer therapies ; Carcinoma - secondary ; Carcinoma - therapy ; Colorectal cancer ; Cytokines ; Drug Therapy, Combination ; Electroporation ; Experiments ; Gene therapy ; Gene Transfer Techniques ; Genetic Therapy - methods ; Herpes viruses ; Interferon-gamma - analysis ; Interleukin-12 - analysis ; Interleukin-12 - genetics ; Kinases ; Lung Neoplasms - pathology ; Lung Neoplasms - secondary ; Lung Neoplasms - therapy ; Melanoma ; Mice ; Mice, Inbred BALB C ; Neurosurgery ; Plasmids ; Plasmids - genetics ; Simplexvirus - enzymology ; Simplexvirus - genetics ; Thymidine Kinase - genetics ; Tumors</subject><ispartof>Molecular therapy, 2004-11, Vol.10 (5), p.929-937</ispartof><rights>Copyright Nature Publishing Group Nov 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-3e89b41ac9f1c6c4a268903799f91ec10aa2902229c4d55398061f6c4209b66f3</citedby><cites>FETCH-LOGICAL-c374t-3e89b41ac9f1c6c4a268903799f91ec10aa2902229c4d55398061f6c4209b66f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1792811389?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>315,781,785,27926,27927,64387,64389,64391,72471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15509510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goto, Tomoaki</creatorcontrib><creatorcontrib>Nishi, Toru</creatorcontrib><creatorcontrib>Kobayashi, Osamu</creatorcontrib><creatorcontrib>Tamura, Takahiko</creatorcontrib><creatorcontrib>Dev, Sukhendu B</creatorcontrib><creatorcontrib>Takeshima, Hideo</creatorcontrib><creatorcontrib>Kochi, Masato</creatorcontrib><creatorcontrib>Kuratsu, Jun-ichi</creatorcontrib><creatorcontrib>Sakata, Tsuneaki</creatorcontrib><creatorcontrib>Ushio, Yukitaka</creatorcontrib><title>Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo</title><title>Molecular therapy</title><addtitle>Mol Ther</addtitle><description>We report the use of plasmid DNA-mediated combination gene therapy for tumor-bearing mice using in vivo electroporation, also called electro-gene therapy (EGT), that resulted in uncomplicated and complete cures in more than 90% of the mice. Subcutaneously inoculated CT26 tumors in syngeneic BALB/c mice were subjected to repeated EGT treatments consisting of intratumoral co-injection of naked plasmids encoding the cytokine interleukin-12 (IL-12) (p35 and p40 subunits) and the suicide gene herpes simplex virus thymidine kinase (HSV-tk), followed by in vivo electroporation. The early anti-tumor effect was always stronger, and the rate of cure, as seen in the long-term follow-up, was always greater in the groups treated with combination EGT than in those treated with IL-12 or HSV-tk EGT alone. Systemic levels of IL-12 and IFN-gamma increased in both combination and IL-12-alone EGT-treated groups. Moreover, combination EGT for established subcutaneous tumors strongly reduced hematogenous lung metastases and increased survival time when live CT26 tumor cells were injected through the tail vein. Limited experiments on C57/B16 mice with murine melanoma also showed very similar trends. These results suggest that this simple and safe method of plasmid-mediated combination EGT may provide a potentially effective gene therapy for cancer.</description><subject>Animals</subject><subject>Cancer therapies</subject><subject>Carcinoma - secondary</subject><subject>Carcinoma - therapy</subject><subject>Colorectal cancer</subject><subject>Cytokines</subject><subject>Drug Therapy, Combination</subject><subject>Electroporation</subject><subject>Experiments</subject><subject>Gene therapy</subject><subject>Gene Transfer Techniques</subject><subject>Genetic Therapy - methods</subject><subject>Herpes viruses</subject><subject>Interferon-gamma - analysis</subject><subject>Interleukin-12 - analysis</subject><subject>Interleukin-12 - genetics</subject><subject>Kinases</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - secondary</subject><subject>Lung Neoplasms - therapy</subject><subject>Melanoma</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neurosurgery</subject><subject>Plasmids</subject><subject>Plasmids - genetics</subject><subject>Simplexvirus - enzymology</subject><subject>Simplexvirus - genetics</subject><subject>Thymidine Kinase - genetics</subject><subject>Tumors</subject><issn>1525-0016</issn><issn>1525-0024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkV2L1DAUhoMo7ucvECQgeNduTtqmzaUMfsGCN-t1yGROZzK2Sc1pl-3P8Z-acQcFr3KSPO-bwMPYGxAlCFB3x3Id5wOWUoi6FG0pZPeCXUIjm0IIWb_8O4O6YFdExzxBo9VrdgFNI3QD4pL92sRx64OdfQwcB3RzisUeA_Jcney08oV82PO8mZD4o08L5at19DufoR85Ssht2HEfZkwDLvmoAMnxaUpIdKqdBkuZJ-6JH_z-MKwc-947j2Hmdm99oJmPSzoVOpucD3G0mQ75ucd4w171diC8Pa_X7Punjw-bL8X9t89fNx_uC1e19VxU2OltDdbpHpxytZWq06Jqte41oANhrdRCSqldvWuaSndCQZ9BKfRWqb66Zu-fe6cUfy5Isxk9ORwGGzAuZFQrQEOrMvjuP_AYlxTy3wy0WnYAVaczVT1TLkWihL2Zkh9tWg0Ic_JnjuaPP3PyZ0Rrsr-cenvuXrYj7v5lzsKq30p1mwk</recordid><startdate>200411</startdate><enddate>200411</enddate><creator>Goto, Tomoaki</creator><creator>Nishi, Toru</creator><creator>Kobayashi, Osamu</creator><creator>Tamura, Takahiko</creator><creator>Dev, Sukhendu B</creator><creator>Takeshima, Hideo</creator><creator>Kochi, Masato</creator><creator>Kuratsu, Jun-ichi</creator><creator>Sakata, Tsuneaki</creator><creator>Ushio, Yukitaka</creator><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>200411</creationdate><title>Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo</title><author>Goto, Tomoaki ; Nishi, Toru ; Kobayashi, Osamu ; Tamura, Takahiko ; Dev, Sukhendu B ; Takeshima, Hideo ; Kochi, Masato ; Kuratsu, Jun-ichi ; Sakata, Tsuneaki ; Ushio, Yukitaka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-3e89b41ac9f1c6c4a268903799f91ec10aa2902229c4d55398061f6c4209b66f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Cancer therapies</topic><topic>Carcinoma - secondary</topic><topic>Carcinoma - therapy</topic><topic>Colorectal cancer</topic><topic>Cytokines</topic><topic>Drug Therapy, Combination</topic><topic>Electroporation</topic><topic>Experiments</topic><topic>Gene therapy</topic><topic>Gene Transfer Techniques</topic><topic>Genetic Therapy - methods</topic><topic>Herpes viruses</topic><topic>Interferon-gamma - analysis</topic><topic>Interleukin-12 - analysis</topic><topic>Interleukin-12 - genetics</topic><topic>Kinases</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - secondary</topic><topic>Lung Neoplasms - therapy</topic><topic>Melanoma</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neurosurgery</topic><topic>Plasmids</topic><topic>Plasmids - genetics</topic><topic>Simplexvirus - enzymology</topic><topic>Simplexvirus - genetics</topic><topic>Thymidine Kinase - genetics</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goto, Tomoaki</creatorcontrib><creatorcontrib>Nishi, Toru</creatorcontrib><creatorcontrib>Kobayashi, Osamu</creatorcontrib><creatorcontrib>Tamura, Takahiko</creatorcontrib><creatorcontrib>Dev, Sukhendu B</creatorcontrib><creatorcontrib>Takeshima, Hideo</creatorcontrib><creatorcontrib>Kochi, Masato</creatorcontrib><creatorcontrib>Kuratsu, Jun-ichi</creatorcontrib><creatorcontrib>Sakata, Tsuneaki</creatorcontrib><creatorcontrib>Ushio, Yukitaka</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goto, Tomoaki</au><au>Nishi, Toru</au><au>Kobayashi, Osamu</au><au>Tamura, Takahiko</au><au>Dev, Sukhendu B</au><au>Takeshima, Hideo</au><au>Kochi, Masato</au><au>Kuratsu, Jun-ichi</au><au>Sakata, Tsuneaki</au><au>Ushio, Yukitaka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo</atitle><jtitle>Molecular therapy</jtitle><addtitle>Mol Ther</addtitle><date>2004-11</date><risdate>2004</risdate><volume>10</volume><issue>5</issue><spage>929</spage><epage>937</epage><pages>929-937</pages><issn>1525-0016</issn><eissn>1525-0024</eissn><abstract>We report the use of plasmid DNA-mediated combination gene therapy for tumor-bearing mice using in vivo electroporation, also called electro-gene therapy (EGT), that resulted in uncomplicated and complete cures in more than 90% of the mice. Subcutaneously inoculated CT26 tumors in syngeneic BALB/c mice were subjected to repeated EGT treatments consisting of intratumoral co-injection of naked plasmids encoding the cytokine interleukin-12 (IL-12) (p35 and p40 subunits) and the suicide gene herpes simplex virus thymidine kinase (HSV-tk), followed by in vivo electroporation. The early anti-tumor effect was always stronger, and the rate of cure, as seen in the long-term follow-up, was always greater in the groups treated with combination EGT than in those treated with IL-12 or HSV-tk EGT alone. Systemic levels of IL-12 and IFN-gamma increased in both combination and IL-12-alone EGT-treated groups. Moreover, combination EGT for established subcutaneous tumors strongly reduced hematogenous lung metastases and increased survival time when live CT26 tumor cells were injected through the tail vein. Limited experiments on C57/B16 mice with murine melanoma also showed very similar trends. These results suggest that this simple and safe method of plasmid-mediated combination EGT may provide a potentially effective gene therapy for cancer.</abstract><cop>United States</cop><pub>Elsevier Limited</pub><pmid>15509510</pmid><doi>10.1016/j.ymthe.2004.07.028</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1525-0016 |
ispartof | Molecular therapy, 2004-11, Vol.10 (5), p.929-937 |
issn | 1525-0016 1525-0024 |
language | eng |
recordid | cdi_proquest_miscellaneous_67019176 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection |
subjects | Animals Cancer therapies Carcinoma - secondary Carcinoma - therapy Colorectal cancer Cytokines Drug Therapy, Combination Electroporation Experiments Gene therapy Gene Transfer Techniques Genetic Therapy - methods Herpes viruses Interferon-gamma - analysis Interleukin-12 - analysis Interleukin-12 - genetics Kinases Lung Neoplasms - pathology Lung Neoplasms - secondary Lung Neoplasms - therapy Melanoma Mice Mice, Inbred BALB C Neurosurgery Plasmids Plasmids - genetics Simplexvirus - enzymology Simplexvirus - genetics Thymidine Kinase - genetics Tumors |
title | Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T04%3A47%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combination%20electro-gene%20therapy%20using%20herpes%20virus%20thymidine%20kinase%20and%20interleukin-12%20expression%20plasmids%20is%20highly%20efficient%20against%20murine%20carcinomas%20in%20vivo&rft.jtitle=Molecular%20therapy&rft.au=Goto,%20Tomoaki&rft.date=2004-11&rft.volume=10&rft.issue=5&rft.spage=929&rft.epage=937&rft.pages=929-937&rft.issn=1525-0016&rft.eissn=1525-0024&rft_id=info:doi/10.1016/j.ymthe.2004.07.028&rft_dat=%3Cproquest_cross%3E67019176%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1792811389&rft_id=info:pmid/15509510&rfr_iscdi=true |